GUIDANCE DOCUMENT
Q12 Technical and Regulatory Considerations for Pharmaceutical Product Lifecycle Management Annex May 2018
Not for implementation. Contains non-binding recommendations.
- Docket Number:
- FDA-2018-D-1609
- Issued by:
-
Guidance Issuing OfficeCenter for Drug Evaluation and Research
At Step 2 of the ICH Process, a consensus draft text or guideline, agreed by the appropriate ICH Expert Working Group, is transmitted by the ICH Assembly to the regulatory authorities of the ICH regions for internal and external consultation, according to national or regional procedures.
Submit Comments
You can submit online or written comments on any guidance at any time (see 21 CFR 10.115(g)(5))
If unable to submit comments online, please mail written comments to:
Dockets Management
Food and Drug Administration
5630 Fishers Lane, Rm 1061
Rockville, MD 20852
All written comments should be identified with this document's docket number: FDA-2018-D-1609.